SCHEMBL93745

SCHEMBL93745

N=[C]CC(O)[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL743717 0.78
SCHEMBL15928779 0.75
SCHEMBL4075597 0.67
SCHEMBL8863208 0.67
SCHEMBL7724278 0.65
SCHEMBL3929 0.65
SCHEMBL3668694 0.65
SCHEMBL2385129 0.65
SCHEMBL6707281 0.65
SCHEMBL11372978 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1828 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230417779-A1 Pregabalin Immunoassays ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT 2023-12-28 US claimed
EP-4288109-A1 IMMUNOSTIMULATORY COMPOUNDS AND CONJUGATES Seagen Inc. (US) 2023-12-13 EP claimed
EP-4288776-A1 COMPOSITIONS AND METHODS FOR PREVENTING NON-SPECIFIC INTERACTIONS BETWEEN POLYMER DYES-ANTIBODY CONJUGATES Beckman Coulter, Inc. (US) 2023-12-13 EP claimed
WO-2023215289-A1 FLUORESCENT DYE FOR PROTEIN OR NUCLEIC ACID LABELING Quantum-Si Incorporated (US) 2023-11-09 WO claimed
EP-4244625-A1 ADDITIVES FOR REDUCING NON-SPECIFIC INTERACTIONS BETWEEN FLUORESCENT POLYMER CONJUGATES AND CELLS IN A BIOLOGICAL SAMPLE Beckman Coulter, Inc. (US) 2023-09-20 EP claimed
EP-4236943-A1 OCULAR IMPLANT CONTAINING AN ACTIVE AGENT Ocular Therapeutix, Inc. (US) 2023-09-06 EP claimed
EP-4216929-A1 SUSTAINED RELEASE BIODEGRADABLE INTRACANALICULAR INSERTS COMPRISING A HYDROGEL AND AN ACTIVE AGENT Ocular Therapeutix, Inc. (US) 2023-08-02 EP claimed
CN-109810198-B Site-specific GLP-2 conjugates utilizing immunoglobulin fragments 韩美科学株式会社 2023-06-06 CN claimed
EP-4182372-A1 FLUORESCENT DYES COMPRISING PI-CONJUGATED 1,1´-BINAPHTHYL-BASED POLYMERS Miltenyi Biotec B.V. & Co. KG (DE) 2023-05-24 EP claimed
WO-2023086103-A1 NOVEL FORMULATION FOR DRYING OF POLYMER DYE CONJUGATED ANTIBODIES BECKMAN COULTER, INC. (US) 2023-05-19 WO claimed
WO-1997007398-A1 POLYPEPTIDE-DENDRIMER COMPLEXES DADE INTERNATIONAL INC. (US) 1997-02-27 WO claimed
EP-0511917-B1 Glycosylated prodrugs, process for their preparation and uses thereof HOECHST SA LAB (FR) 1996-10-23 EP claimed
US-5561119-A ANTITUMOR AGENTS LABORATOIRES HOECHST (FR) 1996-10-01 US claimed
US-5519142-A Homobidental, trifunctional linkers, method for their preparation and use in immunologically active conjugates BOEHRINGER MANNHEIM GMBH (DE) 1996-05-21 US claimed
JP-H08501573-A 1996-02-20 JP claimed
EP-0618192-A1 Homobidental, trifunctional mazeimide linkers and their application in immunologically active conjugates Roche Diagnostics GmbH (DE) 1994-10-05 EP claimed
WO-1994007856-A1 1,4-DISUBSTITUTED PIPERAZINES USEFUL IN THE THERAPY OF THE ASTHMA AND OF THE INFLAMMATION OF THE RESPIRATORY TRACT BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) 1994-04-14 WO claimed
EP-0577659-A1 CROSS-LINKING AGENT. HOLMES MICHAEL JOHN (GB) 1994-01-12 EP claimed
WO-1992017436-A1 CROSS-LINKING AGENT HOLMES, MICHAEL, JOHN (GB) 1992-10-15 WO claimed
EP-0226470-A2 Materials and methods for microchemical testing UNILEVER PLC (GB) 1987-06-24 EP claimed